1
Mitchell E Reff, William S Kloetzer, Takehiko Nakamura: Gamma-1 anti-human CD23 monoclonal antibodies. IDEC Pharmaceuticals Corporation, Seikagaku Corporation, Burns Doane Swecker & Mathis, January 4, 2000: US06011138 (28 worldwide citation)

Anti-human CD23 monoclonal antibodies containing human gamma 1 constant domains and therapeutic uses are provided. These antibodies inhibit IL-4 induced IgE production by B-cells significantly greater than antibodies containing other constant domains.


2
Mitchell E Reff, William S Kloetzer, Takehiko Nakamura: γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics. Biogen Idec MA, Pillsbury Winthrop, April 25, 2006: US07033589 (26 worldwide citation)

Methods for inhibiting production of IgE in a human subject with an IgE-mediated allergic disorder by administering anti-CD23 antibodies.


3
Mitchell E Reff, William S Kloetzer, Takehiko Nakamura: Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics. Biogen Idec MA, Pillsbury Winthrop, May 17, 2005: US06893636 (3 worldwide citation)

Monoclonal antibodies which specifically bind human CD23, the low affinity receptor for IgE (FceRII/CD23), and contain either a human gamma-1 or human gamma-3 constant domain, are disclosed. The antibodies are useful for modulating or inhibiting induced IgE expression. Accordingly, they have practic ...


4
Mitchell E Reff, William S Kloetzer, Takehiko Nakamura: Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics. Biogen Idec MA, Pillsbury Winthrop Shaw Pittman, May 29, 2007: US07223392 (2 worldwide citation)

Monoclonal antibodies which specifically bind human CD23, the low affinity receptor for IgE (FceRII/CD23), and contain either a human gamma-1 or human gamma-3 constant domain, are disclosed. The antibodies are useful for modulating or inhibiting induced IgE expression. Accordingly, they have practic ...


5
Mitchell E Reff, William S Kloetzer, Takehiko Nakamura: Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics. Biogen Idec MA, Pillsbury Winthrop Shaw Pittman, October 21, 2008: US07438906 (1 worldwide citation)

Methods for inhibiting production of IgE in a human subject with an IgE-mediated allergic disorder by administering anti-CD23 antibodies.


6
Mitchell E Reff, William S Kloetzer, Takehiko Nakamura: Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics. Biogen Idec, Pillsbury Winthrop Shaw Pittman, February 19, 2008: US07332163 (1 worldwide citation)

Monoclonal antibodies which specifically bind human CD23, the low affinity receptor for IgE (FceRII/CD23), and contain either a human gamma-1 or human gamma-3 constant domain, are disclosed. The antibodies are useful for modulating or inhibiting induced IgE expression. Accordingly, they have practic ...


7
Mitchell E Reff, William S Kloetzer, Takehiko Nakamura: Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics. Biogen Idec MA, Sterne Kessler Goldstein & Fox P L L C, April 13, 2010: US07695940

Monoclonal antibodies which specifically bind human CD23, the low affinity receptor for IgE (FceRII/CD23), and contain either a human gamma-1 or human gamma-3 constant domain, are disclosed. The antibodies are useful for modulating or inhibiting induced IgE expression. Accordingly, they have practic ...


8
Isami Hamamoto, Keiji Koizumi, Masahiro Kawaguchi, Hisashi Tanigawa, Takehiko Nakamura, Tomomi Kobayashi: Cyclic amine compound and acaricide. Nippon Soda, Foley & Lardner, March 17, 2015: US08980912

The present invention provides a cyclic amine compound represented by formula (I) (in formula (I), Cy1 and Cy2 independently represent a C6-10 aryl group or a heterocyclyl group; R1a to R5a independently represent a hydrogen atom or an unsubstituted or substituted C1-6 alkyl group; R10, R11, R20 and ...


9
Hironori Furukawa, Takehiko Nakamura, Tetsuo Tamai, Daisuke Hanai: Aryloxyurea compound and pest control agent. Nippon Soda, Foley & Lardner, May 12, 2015: US09029601

The present invention provides a pest control agent, acaricide or fungicide that contains, as the active ingredient thereof, at least one type of compound selected from the aryloxyurea compounds represented by formula (V) (wherein R1 to R5 each independently represents an alkyl group or the like, X ...


10
Hironori Furukawa, Takehiko Nakamura, Tetsuo Tamai, Daisuke Hanai: Aryloxyurea compound and pest control agent. Nippon Soda, Foley & Lardner, February 28, 2017: US09580384

The present invention provides a pest control agent, acaricide or fungicide that contains, as the active ingredient thereof, at least one type of compound selected from the aryloxyurea compounds represented by formula (V) (wherein R1 to R5 each independently represents an alkyl group or the like, X ...